BILAAL AHMED: Open Payments
NPI 1225561392 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,662 in 69 payments from 10 companies in 2025. Trend: 2023 $611 · 2024 $1,545 · 2025 $1,662
Food & beverage: $1,662
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 27 | $804 |
| Indivior Inc. | 16 | $285 |
| ViiV Healthcare Company | 14 | $278 |
| Teleflex LLC | 1 | $64 |
| Merck Sharp & Dohme LLC | 3 | $54 |
| Exact Sciences Corporation | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Seqirus USA Inc | 2 | $35 |
| ABBVIE INC. | 1 | $35 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
Products named: SUBLOCADE, CABENUVA, Descovy, Biktarvy, CHOCOLATE, DOVATO, COBENFY, PIFELTRO.
Industry payments across DC — which companies pay providers there.
